高级检索
当前位置: 首页 > 详情页

Salvianolic acid A blocks vasculogenic mimicry formation in human non-small cell lung cancer via PI3K/Akt/mTOR signalling.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Thoracic Surgery, Xiang'an Hospital of Xiamen University, Xiamen, China. [2]Department of Thoracic Surgery, First People's Hospital of Yunnan Province, Kunming, China. [3]Operation Center, The First People's Hospital of Yunnan Province, Kunming, China.
出处:
ISSN:

关键词: Akt non‐ small cell lung cancer salvianolic acid A vasculogenic mimicry

摘要:
Vasculogenic mimicry (VM) is associated with aggressive cancer cells. Salvianolic acid A (Sal-A), an antioxidant and anti-inflammatory agent, has bioactive properties from Salvia miltiorrhiza Bunge. Current investigation aspired to explore the activity of Sal-A in the VM formation of non-small cell lung cancer (NSCLC) and the mechanism underling this function. The CCK8, the scratch and boyden chemotaxis assay were presented to describe NSCLC cells viability, migration and invasion capabilities, respectively. The protein expression was verified by western blotting. In this report, Sal-A caused a reduction in viability, metastasis and capillaries structure formation of NSCLC cells. Additionally, Sal-A markedly prevented the key VM related proteins, containing EphA2, VE-cadherin and MMP2. Besides, Sal-A significantly diminished p-PI3K, p-Akt and p-mTOR level in NSCLC cells. More importantly, SC79 pretreatment reversed Sal-A inhibits NSCLC cells viability, metastasis and VM formation. These data exhibit that Sal-A could block VM network formation in NSCLC cells through modulating the PI3K/Akt/mTOR signalling pathway. © 2021 John Wiley & Sons Australia, Ltd.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 药学 4 区 生理学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 药学 4 区 生理学
JCR分区:
出版当年[2020]版:
Q3 PHYSIOLOGY Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q2 PHYSIOLOGY Q3 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Department of Thoracic Surgery, Xiang'an Hospital of Xiamen University, Xiamen, China.
通讯作者:
通讯机构: [3]Operation Center, The First People's Hospital of Yunnan Province, Kunming, China. [*1]Operation center, The First People's Hospital of Yunnan Province, Kunming 650031, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82478 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号